Feldmann, E <br/><br/>
Cerebrovascular disease with antiphospholipid antibodies: immune mechanisms, significance, and therapeutic options.  [electronic resource] 

 -  Annals of neurology  May 1995 
 - S114-30 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review 
<br/><br/><label>ISSN: </label>0364-5134 
<br/><br/><label>Standard No.: </label>10.1002/ana.410370712  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Hormones--therapeutic use<br/>Animals<br/>Antibodies, Antiphospholipid--immunology<br/>Antibody Specificity<br/>Anticoagulants--therapeutic use<br/>Antiphospholipid Syndrome--complications<br/>Autoantigens--immunology<br/>Blood Coagulation Factors--immunology<br/>Blood Platelets--immunology<br/>Cerebrovascular Disorders--etiology<br/>Endothelium, Vascular--immunology<br/>Female<br/>Fibrinolytic Agents--therapeutic use<br/>Humans<br/>Immunoglobulins, Intravenous--therapeutic use<br/>Immunosuppressive Agents--therapeutic use<br/>Lupus Coagulation Inhibitor--immunology<br/>Male<br/>Plasma Exchange<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Thrombosis--etiology